Chief expert

Ph.D., pharmacy expert in microbiology and biotechnology, academician, professor, doctoral supervisor of Chinese Academy of Engineering, deputy secretary of the Party Committee, president of Wenzhou Medical University, leader of pharmacy discipline, chief expert of the National Engineering Research Center for Genetically Engineered Drugs.

Mr. Li Xiaokun has long been committed to the basic research, engineering technology and new drug development, clinical application and translational medicine research of genetically engineered protein drugs represented by fibroblast growth factor. He developed fibroblast growth factor as a clinical drug for the first time in the world. . Mr. Li Xiaokun has successively won the second prize of National Technological Invention Award, the second prize of National Science and Technology Progress Award, and the first prize of the Ministry of Education Natural Award. Mr. Li Xiaokun has published more than 200 papers in Nature, Cell Metab, Mol Cell, Circulation, etc.

General manager

Undergraduate 

Ms. Chen Xianglin is fully responsible for the operation and management of Liangrunbio. Ms. Chen Xianglin has many years of professional manager experience. She has held senior management positions in Jiakaicheng  Co., Ltd. and other companies. She has rich practical experience in sales team management and enterprise operation management.

Vice President of microdiag

master

Mr. Sun Yulong is a member of the founding team of Liangrunbio, and is mainly responsible for the overall R&D management of each R&D center for Microdiag. Mainly committed to the development of new tumor markers, AD exosome markers, and new crown antibody/antigen detection reagents. The R&D team led by Mr. Sun Yulong has made significant contributions in the discovery of the world's first innovative marker product CST4, the preparation and industrialization of key raw materials, etc.